Skip to main content
Annals of Family Medicine logoLink to Annals of Family Medicine
. 2024 Nov 20;22(Suppl 1):6223. doi: 10.1370/afm.22.s1.6223

Vending machines for harm reduction and community health: a systematic review

Alice Zhang, matthew carrillo, Ryan Liu, Sarah Ballard, Alexis Reedy-Cooper, Aleksandra Zgierska
PMCID: PMC11627631

Abstract

Context:

In response to the growing overdose epidemic, communities in US and Canada have started using vending machines (VMs) as a low-barrier method to provide harm reduction (HR) items to the community. These VMs are becoming popular and typically dispense naloxone, drug testing strips, and other items for co-occurring conditions.

Objective:

To summarize and evaluate existing literature on VMs’ ability to deliver HR and other health items.

Study Design, Analysis:

Systematic literature review. For each eligible article, data was extracted and summarized on study design, goals, VM description, setting, location, target population, sample, results, outcome measures, and limitations.

Dataset:

Embase, Cochrane, PubMED, and MEDLINE (searched from inception to November 29, 2023); references of eligible articles and prior reviews. HR organizations were also contacted to share relevant articles on HR-based VMs.

Population Studied:

Individuals with substance use disorder or co-occurring conditions.

Intervention:

VMs or automated dispensing machines dispensing HR and/or health items.

Outcome Measures:

Feasibility, acceptability, reach, impact.

Results:

Of the 43 eligible articles, few were based in North America (n=10). Most VMs served those who injected drugs (n=27) and dispensed syringes (n=21). Other items included HIV self-tests (n=6), condoms (n=6), naloxone (n=2), and nicotine gum (n=1). Feasibility was most commonly evaluated (n=34), with high demand for VM-dispensed items, especially after business hours. Compared to in-person outreach, some VMs were able to provide more syringes and HIV self-tests. VMs were acceptable (n=20), regardless of item dispensed, and reached high-risk populations (n=14). Outcome measures for impact evaluation (n=16) varied on the dispensed item. Articles evaluating syringe-dispensing VMs’ impact (n=7) noted decreased syringe sharing (n=4) and drug use (n=2), while those evaluating naloxone-dispensing VMs (n=2) reported fewer fatal overdoses.

Conclusions:

VMs providing HR-related items are a promising community-based intervention to reach underserved populations and improve health outcomes. While HR-based VMs have been commonly studied and implemented, VMs could expand into other realms of community health, such as self-sampling kits for detection of cancer or sexually transmitted diseases. Future studies should utilize implementation science frameworks to develop and evaluate the VMs, with an emphasis on health outcomes.


Articles from Annals of Family Medicine are provided here courtesy of Annals of Family Medicine, Inc.

RESOURCES